SCHEMBL13898010

SCHEMBL13898010

O=C1CC[C@H](C(=O)NCCCNc2nc(Nc3cccc(NC(=O)N4CCCC4)c3)ncc2Br)N1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBK1 Q9UHD2 16/20 0.78
MARK3 P27448 3/20 0.78
MARK4 Q96L34 3/20 0.78
STK17A Q9UEE5 3/20 0.78
PDPK1 O15530 6/20 0.68
CDK2 P24941 1/20 0.66
ULK1 O75385 3/20 0.65
PDK1 Q15118 3/20 0.65
ULK2 Q8IYT8 3/20 0.65
AURKA O14965 1/20 0.61
TYK2 P29597 2/20 0.57
AAK1 Q2M2I8 2/20 0.57
MKNK2 Q9HBH9 2/20 0.57
STK17B O94768 1/20 0.57
SIK2 Q9H0K1 1/20 0.57
NUAK1 O60285 2/20 0.56
IKBKE Q14164 1/20 0.56
CGAS Q8N884 1/20 0.56
NTRK1 P04629 2/20 0.56
BMPR2 Q13873 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3867536 1.00 TBK1 (0.78) TBK1MARK3MARK4STK17APDPK1
SCHEMBL3865985 1.00 TBK1 (0.78) TBK1MARK3MARK4STK17APDPK1
SCHEMBL3868613 0.93 TBK1 (0.78) TBK1MARK3MARK4STK17APDPK1
SCHEMBL13897890 0.92 TBK1 (0.65) TBK1MARK3MARK4STK17APDPK1
SCHEMBL13898187 0.89 TBK1 (0.75) TBK1MARK3MARK4STK17APDPK1
SCHEMBL13898191 0.89 TBK1 (0.79) TBK1MARK3MARK4STK17APDPK1
SCHEMBL13898060 0.89 TBK1 (0.79) TBK1MARK3MARK4STK17APDPK1
SCHEMBL13898053 0.89 TBK1 (0.95) TBK1MARK3MARK4STK17APDPK1
SCHEMBL3874640 0.88 TBK1 (0.74) TBK1MARK3MARK4STK17APDPK1
SCHEMBL13898257 0.88 TBK1 (0.78) TBK1MARK3MARK4STK17APDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504410-B2 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 2009-03-17 US disclosed
US-7504410-B2 Chk-, Pdk- and Akt-inhibitory pyrimidines, their production and use as pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 2009-03-17 US disclosed